Fischer Imaging, Philips Medical team for women's healthcare

Afforded a $468,000 research grant, Fischer Imaging Corp. will collaborate with Philips Medical Systems' ultrasound business in Bothell, Wash., to arrange development studies for an integrated ultrasound and digital mammography system.

The Phase I small business innovation research grant was issued to the Denver-based Fischer Imaging from the National Cancer Institute of the National Institutes of Health (NIH). The project stems from recent studies suggesting high-quality breast ultrasound can find additional cancers in women with dense breasts after undergoing standard screening mammography and diagnosed negative for cancer.

 "This research project is an example of two well-accepted imaging modalities which, when combined, can potentially generate substantial improvements in diagnostic accuracy," said Victor Reddick, senior vice president of Philips ultrasound. "Our goal will be to acquire both ultrasound and digital mammography images concurrently, producing a higher sensitivity and specificity for screening tests."

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.